Pledging mutual funds, equity shares, bonds, and other approved securities for overdraft liquidity without selling. LAS product structure, Drawing Power mechanics and daily recomputation, depository pledge process (NSDL/CDSL), margin call triggers and invocation sequence, four named-borrower journeys — Ashwin's school-fees bridge, Devika's 36-hour medical emergency, Hemant's leveraged-investment forced sale (the cautionary tale), and Jagan's clinic-equipment Section 36(1)(iii) deduction — and why using LAS to buy more securities is structurally self-destructive.
LAS is the most operationally different loan product covered so far. Every other secured loan we've examined — home, auto, education with collateral, gold, MSME with hypothecation, agricultural with land pledge, LAP — uses a relatively stable, slowly-priced asset as collateral. Even gold, which has daily price discovery, moves at percentages that rarely trigger same-day margin events. LAS uses securities — shares, mutual funds, bonds — that mark to market continuously, with prices that can fall 5-10% in a single trading session during stress periods.
This single fact reorganizes the entire product. There is no SARFAESI invocation (you don't need to take possession of pledged shares — the depository moves them on lender instruction). There is no Sub-Registrar visit. There is no mortgage deed. There is no auction. Instead, there is margin call mechanics: if your collateral value drops below the threshold required to support your outstanding drawing, the lender calls you to either pledge more securities, deposit cash, or face forced sale of your pledged scrips in the open market within hours. The borrower-side experience is closer to derivatives trading than to traditional lending.
LAS exists because India's expanding equity culture has created a large class of households whose biggest asset (after their home) is their mutual fund portfolio + direct equity holdings. A senior software engineer in Bengaluru with 20 years of SIPs might have ₹40-60L in mutual funds; a doctor with stock holdings in pharma + tech might have ₹50-80L in direct equity. Liquidating these holdings for a medical emergency, child's education, or business need would trigger LTCG tax + forfeit future growth. LAS unlocks the value at the cost of pledge + interest, similar to how LAP unlocks home equity.
But LAS carries a danger LAP doesn't: the collateral can fall in value precisely when you most need it. A borrower who took LAS in early 2024 against a portfolio of small-cap mutual funds at the market peak, expecting 12% returns to outpace the 10.5% LAS rate, would have faced 25-30% drawdowns by mid-2025 — triggering margin calls during the exact period when the temptation is to "wait for recovery" rather than realize losses by selling. LAS amplifies market stress for the borrower because the loan demands cash precisely when cash is hardest to come by.
This lesson covers the LAS product structure, approved securities and DP mechanics, Ashwin's clean LAS journey for daughter's school fees, Devika's medical-emergency LAS execution under time pressure, Hemant's leveraged-investment story that ended in forced sale (the cautionary tale), and Jagan's business-use LAS with Section 36(1)(iii) treatment. We also examine how margin calls work in practice and what borrowers can do — and should not do — when they receive one.
Lessons 1 (Foundation, especially demat account grounding), 2 (Home loans for general mortgage concepts), 10 (LAP for end-use and tax treatment parallels). Lesson 10 covered Section 24(b)/80C/36(1)(iii) thoroughly — those provisions apply identically to LAS for tax treatment, so we cross-reference rather than re-ground.
Key terms
Loan Against Securities (LAS): A loan facility, typically structured as an overdraft (OD), where the borrower pledges approved securities (equity shares, mutual fund units, bonds, NSCs, KVPs, insurance policies) held in their demat account or as physical certificates to a lender, in return for a drawing limit set as a percentage (LTV) of the securities' market value. The lender is typically a bank or NBFC; pledge is recorded in the depository system.
Ashwin has ₹40L in equity mutual funds + ₹8L in HDFC Bank shares (₹48L portfolio). His LAS lender allows 50% LTV on equity MFs and 50% LTV on Group A equity shares. His sanctioned LAS limit = (₹40L × 50%) + (₹8L × 50%) = ₹20L + ₹4L = ₹24L. He chooses to take a ₹15L LAS facility — borrowing only what he needs, well under the ₹24L ceiling.
Pledge (LAS-specific): The act of marking specific securities in the borrower's demat account as "pledged" in favor of the lender. The borrower retains beneficial ownership (dividends, voting rights, corporate actions accrue to borrower) but cannot sell or transfer the pledged shares without the lender's release. Operationally different from "hypothecation" used in LAP/auto loans — pledge is a depository-level lock, not a contractual charge.
Depository System: India has two depositories — NSDL (National Securities Depository Ltd) and CDSL (Central Depository Services Ltd). Both maintain electronic records of securities ownership. Pledge requests for LAS flow through whichever depository holds the borrower's demat account. Most retail demat accounts at brokers like Zerodha, Groww, and Upstox are on CDSL; bank-affiliated brokers like HDFC Securities, ICICI Direct are typically on NSDL.
Approved Securities List: Each lender maintains a list of securities they accept as LAS collateral. The list typically includes:
The approved list is updated quarterly; not all scrips qualify even from approved AMCs (close-ended funds, recently launched funds with no track record, sector-specific high-volatility funds may be excluded).
Haircut / Scrip Margin: The percentage discount applied to a security's market value to arrive at its eligible collateral value. Higher-quality securities get smaller haircuts. For instance, if HDFC Bank shares are at ₹1,800 and the haircut is 50%, eligible collateral value per share = ₹900. The full approved securities widget below shows scrip-specific haircuts.
Drawing Power (DP) for LAS: Computed daily after market close. Formula: DP = Σ (Security Market Value × Approved LTV%). If Ashwin's portfolio at market close on Day X has equity MFs worth ₹40L (50% LTV → ₹20L) + HDFC Bank shares worth ₹8L (50% LTV → ₹4L), his DP for Day X+1 = ₹24L. If equity markets fall 5% the next day, his DP for Day X+2 falls to about ₹22.8L.
Sanctioned Limit vs DP vs Outstanding: Three different numbers, easy to confuse:
The constraint is: Outstanding ≤ MIN(Sanctioned Limit, DP). If portfolio falls and DP drops below outstanding, margin call is triggered.
Overdraft (OD) Structure: Most LAS facilities are structured as ODs. Borrower has a current account with attached OD line; draws as needed (cheques, online transfer, debit card), interest accrued daily on debit balance, payable monthly. No EMI; the borrower can draw, repay, redraw freely within the limit. This is the "credit line" structure familiar from cash credit (L8 MSME) — but with securities as collateral instead of inventory.
Interest Computation: Daily product method on debit balance. Rate is typically RLLR + 2.5% to 4% spread. Charged monthly. Example: Ashwin's ₹15L LAS at 10.5% — if his average outstanding is ₹8L for a month, his interest for that month = ₹8L × 10.5% × (30/365) = ₹6,904.
Margin Call: Lender's demand to the borrower to either (a) pledge additional approved securities, (b) deposit cash to reduce outstanding, or (c) repay enough to bring outstanding below the now-lower DP. Triggered when outstanding > DP, typically after a market session sees portfolio drop. Time window for cure: typically 24-72 hours, but lenders have discretion in extreme volatility to compress this.
Initial Margin vs Maintenance Margin (concept from broking applied to LAS):
Invocation / Forced Sale: If margin call is not cured within stipulated time, lender invokes the pledge — instructs depository to transfer pledged shares from borrower's pledged account to lender's account, then sells in open market to recover outstanding. Sale is typically through lender's broking arm at market prices; whatever surplus remains after recovery + costs is returned to borrower. There is no court process and no notice beyond the margin call.
Section 36(1)(iii) for LAS: Same as LAP — if proceeds are used for business, interest is deductible under business income head. The CA end-use certificate framework from L10 applies identically. We cross-reference rather than re-detail.
Restrictions on Promoter Holdings: SEBI Prohibition of Insider Trading Regulations + LODR Regulations restrict promoters or persons holding >10% in listed companies from pledging their shares without specific disclosure. The pledge itself becomes a "material disclosure" event. LAS facilities for such borrowers go through additional compliance.
End-Use Restrictions (RBI-mandated): Under RBI Master Direction on Bank Lending Against Shares (2017), banks cannot lend LAS proceeds for:
NBFC LAS is similarly restricted under NBFC LAS guidelines (2016). End-use compliance is monitored via the borrower's current account flows.
| Security Type | Typical LTV |
|---|---|
| Government securities (G-Secs) | 80-85% |
| AAA-rated corporate bonds | 75-80% |
| Mutual fund units — Debt funds | 75-80% |
| Mutual fund units — Hybrid funds | 65-75% |
| Mutual fund units — Equity funds | 55-65% |
| Listed equity shares (approved list) | 50-55% |
| Listed equity shares (not in approved list) | 40-50% (some lenders refuse) |
| ETFs (depending on underlying) | 55-75% |
| Insurance policies (with surrender value) | 80-90% |
The pattern: more stable assets get higher LTV. G-Secs at 85% vs. equity at 55% reflects the dramatically different volatility profiles.
Beyond per-security LTV, lenders impose concentration limits: • Maximum exposure to a single security: typically 30-40% of total loan • Maximum exposure to a single sector: typically 50-60% • Maximum exposure to small-cap stocks: typically 20-30% These limits prevent over-concentration that would create severe margin call risk. A well-diversified portfolio across blue-chips, debt instruments, and mutual funds can support 55-65% of value as loan. A concentrated equity portfolio in small-caps might support only 20-30% of value.
Before taking LAS, compute both paths: • Sell ₹X worth of securities to meet need: cost = capital gains tax + opportunity cost of appreciation foregone • Take ₹X LAS: cost = interest over expected tenure + margin call risk If LAS cost is comparable to or higher than selling cost, the convenience of LAS isn't worth the margin call risk. Sell instead.
| Lender Type | Strengths | Best For |
|---|---|---|
| Banks with broking arm (HDFC, ICICI, Axis, Kotak, SBI) | Tight integration with demat; instant DP recomputation; lowest rates 10.0-10.5%; OD via existing CA | Customers with demat at the bank's broking subsidiary |
| Banks without broking (PNB, BoB, BoM, Canara) | Available to customers with external demat (Zerodha, Groww); slightly slower DP updates | Customers wanting bank reliability with non-bank broker |
| NBFC LAS specialists (Bajaj Finance, Aditya Birla Capital, Tata Capital) | Faster sanction; broader approved scrip list; less paperwork | Customers with diversified or smaller portfolios |
| Securities firm LAS (Kotak Securities, ICICI Direct, Motilal Oswal) | Same-broker pledge mechanics; integrated with trading account | Active traders with sizeable portfolios |
| Loan-against-MF specialists (Bajaj Finserv, ICICI Bank's eLAP) | Specialized for MF-only collateral; digital end-to-end | MF-only investors |
RBI Master Direction on Bank Lending against Shares (Master Direction DBR.No.Dir.BC.74/13.03.00/2017-18 dated 7 May 2018, as amended); SEBI Substantial Acquisition of Shares and Takeovers Regulations 2011; SEBI Prohibition of Insider Trading Regulations 2015; Depositories Act 1996; NSDL/CDSL Bye-Laws; NBFC Loans against Shares Direction 2016.
Lenders publish their approved securities list as part of LAS documentation. The list reveals which scrips count toward DP and at what discount. Here is the structure of a typical bank's approved scrips list as Ashwin would encounter:
Setup
Ashwin, 46, senior engineering manager at an IT product company in Bengaluru. Salary ₹3.8L/month. Married, two kids (10 and 7). Lives in a self-owned 3-BHK in HSR Layout (home loan still running, ~₹38L outstanding).
His investment portfolio at 31 January 2027:
In February 2027, two simultaneous cash needs arise:
Total need: ₹15L. Within 45 days.
Options he considers:
The math strongly favors LAS for short-term need. He approaches HDFC Bank (his salary account, HDFC Securities demat).
Step 1: LAS application and sanction
Ashwin's LAS application is processed end-to-end in 3 days (his demat is with HDFC Securities, salary account with HDFC Bank — same group, instant data pull). The sanction letter arrives 4 February 2027:
Step 2: Depository pledge — the crucial mechanic
The day after sanction acceptance, Ashwin logs into HDFC Securities and initiates the pledge. Because his demat is with HDFC Securities (NSDL-affiliated), the pledge happens within the NSDL system; for borrowers with CDSL demat (most retail customers at Zerodha, Groww), the same mechanic happens through CDSL.
The pledge process is fully online for retail LAS — Ashwin doesn't visit a branch. Steps:
The pledge confirmation slip from NSDL — the document evidencing the pledge — looks like this:
Step 3: Drawing and DP holding statement
With pledge complete on 6 February 2027, Ashwin's LAS OD is "active." He has a current account number for the LAS facility; any withdrawal from that account creates an OD debit balance (= drawing).
Ashwin draws:
Total drawn: ₹14,80,000 out of ₹15,00,000 sanctioned limit.
Each month, HDFC Bank sends a DP holding statement that shows the daily DP computation alongside the outstanding balance and interest accrual:
Step 4: Repayment + closure
On 5 June 2027, Ashwin's home loan top-up sanction comes through (his original home loan ₹38L outstanding + ₹15L top-up = new combined ₹53L home loan at 8.7%). The top-up disbursement is used to fully repay the LAS outstanding (₹14,90,000 including 4 months of interest).
He requests LAS closure on 8 June 2027. Bank initiates unpledge request via NSDL; Ashwin's OTP confirms it; by 10 June 2027 all 5 holdings show "Free" status in his demat. The LAS account is closed.
| Item | Amount (₹) |
|---|---|
| Processing fee + GST + stamp | 8,850 |
| Interest charges (Feb-June 2027) | ~46,200 |
| Total LAS cost | ~55,050 |
| Alternative: ₹15L personal loan at 13% × 5 months ≈ | ~81,250 + ₹15K PF |
| Alternative: liquidate ₹15L from MFs + ₹1.8L LTCG tax | ₹1,80,000+ |
| Net saving over alternatives | ~₹1.4-2.5L |
This is what productive short-term LAS looks like — bridging a temporary cash need at meaningfully lower cost than alternatives, with the borrower's portfolio thesis intact.
Setup
Devika, 49, independent management consultant in Mumbai (Bandra). Lives alone in a rented 1-BHK; parents in Ahmedabad. No dependents directly relying on her income.
Her financial portfolio at September 2027:
On 14 September 2027, Devika is diagnosed with Stage 2 breast cancer. Her oncologist recommends immediate treatment: mastectomy + chemotherapy + radiation + targeted therapy if HER2+. Estimated total treatment cost over 9 months at a private hospital in Mumbai (Lilavati): ₹18-22L. Her health insurance covers ₹15L. Out-of-pocket shortfall: ₹3-7L plus working capital for the 6 months her consulting income will reduce.
Total cash need: ₹12L within 72 hours (initial hospital deposit + surgery costs are demanded upfront before admission).
She considers her options under time pressure:
LAS is clearly the right tool. She approaches ICICI Bank (her primary banker, ICICI Direct demat).
Time-pressure execution
The whole LAS journey for Devika compresses to ~36 hours:
Day 0 (15 September 2027 — Monday):
Day 1 (16 September 2027 — Tuesday):
The remaining ₹7.5L is drawn over the next 6 weeks as surgery, chemotherapy cycles, and follow-up costs come due.
Devika's economic outcome
| Element | Detail |
|---|---|
| LAS sanctioned | ₹12L |
| LAS drawn (peak outstanding) | ₹11.85L |
| Interest rate | 10.45% |
| Average outstanding over 9 months | ₹9.8L |
| Total interest cost over 9 months | ~₹74,500 |
| Processing + stamp + misc | ~₹7,500 |
| Total LAS cost | ~₹82,000 |
Compare to alternatives: Liquidating ₹12L from MFs: ₹80K LTCG + ~₹1.5L lost growth over 9 months (market did appreciate ~8% in this period) = ~₹2.3L total opportunity cost. Personal loan ₹12L at 13%: ~₹1.05L interest cost + ₹18K PF = ~₹1.23L.
LAS saved Devika roughly ₹40K-1.5L compared to alternatives, and crucially, avoided the time delay of MF redemption that would have postponed her surgery by 3-5 days.
She also retained her portfolio thesis — her SIPs continued throughout treatment, units accumulating in her demat (the new SIP units went to "Free" balance, not auto-pledged). By February 2028, her treatment was complete, her consulting work was resuming, and she repaid LAS in 3 installments from accumulated business receipts over the following 6 months. Portfolio fully unpledged by June 2028. Total cost of borrowing was less than 2% of her portfolio value — for a life-saving medical intervention completed without selling a single MF unit.
The structural insight: LAS shines brightest in genuine emergencies precisely because of its speed and minimal disruption to the underlying portfolio. Slow-motion needs (wedding 8 months away, vacation, home renovation that can wait) are better served by LAP or other instruments where you have time to plan and the margin call risk over 12+ months tenure is meaningful. Fast, finite emergencies — medical, accidental — are LAS's natural use case.
RBI Master Direction on LAS; ICICI Bank LAS product documentation; standard banking practice for digital LAS execution at major Indian banks.
Setup
Hemant, 43, runs a small printing and packaging business in Delhi (Karol Bagh). The business is moderately profitable but cyclical. He has been investing aggressively in mid-cap and small-cap mutual funds since 2019. By December 2024, his MF portfolio had grown to ₹22L. He had no LAS or other loan at that point.
In early January 2025, the Indian equity market was extending a strong rally that had begun in mid-2023. Nifty Smallcap 250 had returned ~50% in 2024. Hemant's small-cap heavy portfolio was up significantly. He had developed a thesis: "small-caps will continue to outperform; if I can deploy more capital, I can compound faster."
His advisor (an MF distributor with limited risk awareness) suggested he take an LAS against his portfolio and use the proceeds to buy "promising small-cap stocks directly." Hemant knew vaguely that LAS proceeds couldn't be used for stock purchase, but the advisor explained that the bank's monitoring "only checked end-use if asked, and you can show any business expense."
This is the precise mechanism by which LAS gets weaponized into an unauthorized margin trading scheme. Hemant proceeded.
The LAS and the leveraged stock purchases
February 2025: Hemant secures LAS facility from an NBFC (Bajaj Finance) for ₹10L against his ₹22L MF portfolio. Sanctioned at 50% LTV for MFs (mostly small-cap) = DP ₹8.8L. He requested and got ₹10L sanctioned with the additional cushion coming from his ICICI Bank shares (₹2L) also being pledged.
Rate: 11.5%. OD structure.
March-May 2025: He draws ₹8L over three months and uses it to buy "promising" small-cap stocks directly through his Zerodha account — bypassing the OD's end-use prohibition by transferring drawn funds first to his "business" current account, then to his personal savings, then to Zerodha. The transactions were structured to avoid easy detection.
By end of May 2025, his portfolio (combined original MFs + new direct equity bought with LAS funds) had grown to ~₹38L on paper. His LAS outstanding was ₹8.2L (including accrued interest). Buffer looked comfortable.
Then the market turned.
The 2025 correction
June 2025 saw a sharp correction in Indian equities, particularly small-caps:
By 25 July 2025, his combined portfolio (MFs + new direct equity) had crashed from ₹38L to ₹27L. His LAS outstanding (now with interest accrued) was ₹8.4L.
DP computation at 25 July 2025 close:
Outstanding: ₹8.4L. Buffer ratio: 151%. Still healthy.
But the market kept falling.
Margin call sequence
Over the next 14 trading days (26 July to 12 August 2025):
By 12 August 2025 close:
Outstanding: ₹8.45L. Buffer: 109%. Below the 110% trigger.
Bajaj Finance issues the first margin call:
Hemant's response to the first margin call
Hemant receives the SMS + email at 9:15 AM on 13 August 2025. He has 48 hours. His options:
| Option | Hemant's situation |
|---|---|
| Deposit ₹75,500 cash | He has ~₹40K in his savings; business OD already maxed at his own bank (Indian Bank); would need to liquidate something |
| Pledge ₹1.5L more securities | He has no other approved scrips beyond what's already pledged |
| Sell some of his pledged scrips to deleverage | The depository pledge prevents direct sale; would need lender's release first (which won't happen without paying down) |
| Liquidate non-pledged assets | His business equipment isn't liquidatable in 48 hours |
| Borrow ₹75K from family | Possible but humiliating; also a temporary fix |
Hemant chooses the temporary fix — borrows ₹80K from his brother (loan of love) on 14 August, deposits it into the LAS OD, brings outstanding down to ₹7.65L. With unchanged DP ₹9.25L, new buffer = 121%. Above the 110% trigger. First margin call cured.
But the underlying problem isn't solved. He's still over-leveraged in a falling market. He hasn't sold any positions because his thesis is that markets will recover.
The second margin call (final)
Three trading days later (18 August 2025), markets fall another 4%. His pledged portfolio falls in value again:
Below 110% again. Second margin call issued 19 August 2025. This time the notice is the Final Margin Call — 24-hour cure window (not 48 hours), no further extensions.
Hemant cannot cure. He has no more family loans available; he has no other securities; he has no cash. He calls Bajaj Finance's RM hoping for an extension.
The RM: "Sir, this is the final notice. If buffer isn't restored by tomorrow 5 PM, we will invoke. You can sell your direct equity holdings yourself before that to clear the loan if you prefer — but I cannot extend the deadline. Markets are volatile."
Hemant tries to sell some of his direct equity holdings he bought with LAS funds (those that aren't already pledged with Bajaj) on 20 August. But those direct holdings had also been pledged (he had added them as additional security mid-LAS to extend his drawing capacity). All his holdings are encumbered.
The forced sale (invocation)
By 5 PM 20 August 2025, no cure.
On 21 August 2025 morning, Bajaj Finance files an Invocation Request with CDSL and NSDL covering all of Hemant's pledged holdings. By 10:30 AM the depositories execute the transfer — Hemant's MF units and direct equity holdings move from his demat (marked "Pledged") to Bajaj Finance's demat (marked "Free"). Hemant receives an SMS confirming the invocation.
Bajaj Finance's broking arm begins selling the holdings in the open market over 21-22 August. The sales are at market prices, in market lots, executed at varied prices:
Hemant's outcome and lessons
| Item | Value (₹) |
|---|---|
| Original portfolio value (December 2024 peak) | 22,00,000 |
| Original portfolio value (February 2025, LAS sanction) | 22,00,000 |
| Portfolio + direct equity bought with LAS funds (May 2025 peak) | 38,00,000 |
| Total sale proceeds at forced sale | 10,65,650 |
| LAS outstanding at invocation | 7,82,400 |
| Surplus returned to Hemant | 2,71,007 |
| Net wealth destruction from peak | ~35,29,000 |
| Net wealth destruction from original (pre-LAS) | ~19,29,000 |
| Tax liability for FY 2025-26 (CA estimate) | ~₹1,80,000 (LTCG + STCG mix from forced sale) |
| CIBIL impact | "Invocation" tag for 7 years; significant rating drop |
Three lessons from Hemant's story:
The proper antidote isn't avoiding LAS — Ashwin and Devika used it well — but understanding when LAS works and when it doesn't. Short-term, finite-purpose drawing against a portfolio you'd hold anyway is sound. Using LAS to amplify portfolio bets is hidden margin trading and is structurally hostile to the borrower in any market other than a one-way bull run.
RBI Master Direction on Bank Lending against Shares (paragraphs on end-use prohibition); SEBI broker margin trading regulations (for comparison purposes); banking industry margin call and invocation practice; CIBIL reporting standards for invoked LAS.
The structural takeaway from Hemant's NBFC sanction: Three things visible that distinguish his situation from Ashwin's bank LAS that contributed to the eventual forced-sale outcome: 1. Tighter initial buffer (5.7% vs Ashwin's 15.3%) — Bajaj sanctioned ₹10L against DP ₹10.58L, leaving very little room for market drawdown before margin call. 2. Higher rate (11.5% vs Ashwin's 10.30%) — 120 bps more expensive, compounding cost over months of holding the position. 3. Self-certification end-use monitoring — the "self-certification" language is what created the loophole Hemant exploited. Bank LAS often has stricter monitoring (bank can see current account flows directly); NBFC LAS relies on borrower's word. NBFC LAS isn't inherently bad — for borrowers who genuinely can't access bank LAS (insufficient banking relationship, non-standard collateral mix), it's a legitimate product. But borrowers should know the cost differential and stricter cure-window structure before signing.
Setup — efficient pairing
Jagan, 52, a consulting cardiologist in Hyderabad. Runs his own clinic in Banjara Hills (started 2018). Investment portfolio at December 2027:
In December 2027, he decides to upgrade his clinic's diagnostic equipment — a new echocardiograph (₹14L), upgraded ECG (₹3L), patient monitoring system (₹5L), reception + waiting area renovation (₹3L). Total need: ₹25L.
Options he considers:
LAS pairs efficiently with his needs — and unlike Hemant, he understands the rules. He approaches ICICI Bank.
Sanction + business end-use
ICICI sanctions ₹25L LAS against his ₹63L portfolio (DP ~₹36L easily covers the ₹25L request). Rate: 10.4%. OD structure, 12-month tenure renewable.
Drawing schedule:
Total drawn: ₹25L.
The CA end-use certificate framework from L10 applies identically. Jagan's CA prepares the certificate substantiating 100% business use, attaches vendor invoices, GST registrations, and equipment delivery proofs. The Section 36(1)(iii) deduction kicks in.
Tax outcome
| Item | Value (₹) |
|---|---|
| Average outstanding (year 1) | 22,00,000 |
| Annual interest paid | 2,29,000 |
| Section 36(1)(iii) deduction (full, no upper cap) | 2,29,000 |
| Marginal slab (30%) | -- |
| Tax saved | 68,700 |
| Effective post-tax interest rate | 10.4% × (1 − 30%) = 7.28% |
Compare to:
LAS gave Jagan the cheapest after-tax cost of capital for his equipment financing while preserving the portfolio. The clinic upgrade pays back through increased patient throughput (echocardiography is a high-margin service); he targets full LAS closure within 24 months from clinic cash flow.
The structural insight: LAS for business equipment is a powerful pairing for self-employed professionals (doctors, lawyers, consultants, architects) who have significant securities portfolios but limited business assets to mortgage. The Section 36(1)(iii) deduction transforms the economics; the OD structure matches the operating cash flow rhythm.
Section 36(1)(iii) Income Tax Act (interest on capital borrowed for business); ICAI tax practice notes on professional firm financing; banking industry LAS for professionals product positioning.
This subsection deserves its own treatment because using LAS proceeds to buy more securities is the single most common LAS misuse and the path Hemant took. Setting aside the regulatory question (it's prohibited under RBI Master Direction), there are four financial reasons it's structurally bad:
The mental model is "I'm leveraging my conviction." The financial reality is "I'm doubling down at a structurally unfavorable price." Even professional fund managers running leveraged strategies use hedging instruments (derivatives, options) that retail LAS borrowers lack access to.
Don't borrow against securities to buy securities. Not for IPOs, not for "high-conviction" stocks, not for crypto, not for SIPs. If you genuinely want more equity exposure than your current capital allows, increase your monthly SIP allocation — the cost is in waiting, not in leverage.
RBI Master Direction on Bank Lending against Shares paragraph on prohibited end-uses; behavioral finance research on leveraged retail investing outcomes; SEBI investor education materials on margin trading risks.
| Mistake | Cost | Avoidance |
|---|---|---|
| Treating LAS as a long-tenure loan | Market drawdown over years almost guarantees margin call episodes | Use LAS for 3-12 month needs; for longer, LAP or term loan |
| Pledging concentrated single-scrip portfolio | Sharp fall in that scrip triggers immediate margin call with no diversification cushion | Pledge diversified portfolio; multiple AMCs, multiple sectors |
| Drawing close to DP at sanction | First market dip puts you in margin call territory | Draw 60-70% of DP, keep 30-40% buffer |
| Not monitoring DP during volatility | Margin call SMS missed; cure window passes; forced sale | Set up alerts; review DP weekly in normal times, daily in volatility |
| Using LAS for stock purchases | Hemant scenario - leverage amplifies losses, forced sale at trough | NEVER use LAS for securities; for IPOs, for crypto, for any market investment |
| Pledging emergency fund (liquid MFs) entirely | When you need cash emergency separately, no unencumbered liquid corpus left | Keep at least 6 months expenses in unpledged liquid fund |
| Concentrating on small-cap MFs alone | Highest haircut, highest volatility, fastest DP swings | Mix large-cap, multi-cap, debt for stable DP; small-caps as small portion |
| Not understanding maintenance margin | Surprise margin call when buffer falls; panic decisions | Read sanction letter; know your 110% threshold; calculate cure amounts in advance |
| Family-loan to cure margin call | Temporary fix; underlying over-leverage unaddressed; deeper hole later | Cure by reducing outstanding (paying down) or accepting partial forced sale early |
| Lending against employee ESOPs near lock-in expiry | If pledge invoked, mandatory lock-in violation creates company-level complications | Wait until ESOPs are vested and outside lock-in before pledging |
| Borrower with promoter stake forgetting SEBI disclosure | Insider trading violation; SEBI penalty; pledge disclosure missed | If you're a promoter or hold over 10% in any listed entity, get securities lawyer review before pledging |
| Not aware of approved scrip changes | Scrip removed from approved list mid-tenure; DP suddenly drops; margin call | Read quarterly updates; substitute or reduce drawing proactively |
| Believing LAS is "safer" than LAP because shares are liquid | Liquidity cuts both ways - sale execution is faster but at worst prices | Both are dangerous if misused; LAS speed cuts both for borrower and lender |
| Drawing for consumption (wedding, luxury) | No tax benefit; long repayment horizon increases margin call episodes | Use LAP for non-business multi-year consumption; not LAS |
| Closing LAS partially without checking unpledge sequence | Lender may not release proportional collateral; some scrips remain locked unnecessarily | Specify which scrips to release; verify post-closure that demat shows "Free" |
| Ignoring annual review/renewal | LAS auto-cancels if renewal not signed; outstanding becomes immediately due | Calendar the renewal date; sign 30 days in advance |
Active management during volatile periods can be the difference between modest cost and significant loss.
Daily monitoring practices. Once you have active LAS:
Most lenders provide this tracking through their app or portal. Use it.
Pre-emptive action thresholds. Don't wait for margin call to act. Set your own thresholds:
| Ratio Level | Action |
|---|---|
| Above 1.8x | Normal — no action |
| 1.5-1.8x | Monitor closely; review weekly |
| 1.4-1.5x | Consider preemptive action: bring collateral or partial repay |
| 1.35-1.4x | Definitely act: don't wait for margin call |
| At 1.33x | Margin call zone — must act immediately |
Acting pre-emptively (when ratio is 1.4x, not 1.33x) gives you time to choose how to respond rather than reacting under pressure.
Options during volatile markets:
If you experienced margin call and had partial forced sale: don't immediately try to "make back" the loss with new LAS leverage. Restore portfolio carefully over time. Learn the experience — adjust future LAS usage to lower LTV with bigger buffer. Consider whether LAS is the right product for your situation.
Patterns suggesting caution.
Some lenders offer higher LTV than standard (65% on equity vs. typical 50-55%). This means less buffer, more margin call risk. The "more loan" attraction comes with higher hazard.
Some lenders accept volatile stocks at apparently good LTV, then aggressively manage margin calls. The combination creates predatory dynamics.
Lender's communication about how margin calls work is vague. "We'll inform you" without specifics on timeline, methods, or your options. When margin call comes, you have no framework to respond.
Beyond interest, watch for: pledge creation/release fees per security, annual maintenance charges, daily/monthly statement fees, renewal fees. Individually modest; cumulatively meaningful, especially for smaller loans.
At annual renewal, some lenders increase rates or reduce LTV based on "current market conditions." If you're not in position to refuse (still need the loan), you accept worse terms. Get renewal terms agreed in advance where possible.
Some lenders sell pledged securities aggressively at small margin call triggers, beyond what's necessary. The forced sale may exceed the minimum required to restore margin. This causes unnecessary losses for borrowers.
If you're an insider (employee with restricted shares, founder, executive), pledging your shares may have regulatory implications. SEBI rules on pledge of promoter shares are strict. Verify your specific situation before pledging.
LAS to fund trading positions creates compound leverage. The trading account already has margin requirements; LAS adds another layer. Combined leverage during volatile markets is the source of many large losses.
If you've recently received shares from ESOP vesting or restrictions lifting, pledging them immediately may have tax implications (perceived as monetization). Consult tax advisor before pledging recently-received securities.
No legitimate LAS product can promise no margin call — that's the structural design. If a lender or sales rep claims otherwise, they're misrepresenting the product. Read the actual agreement carefully.
RBI Master Direction on Loans Against Securities; SEBI guidelines on pledge of shares; consumer complaints in LAS segment.
Key Takeaways
What is the correct constraint that must hold continuously in an active LAS facility?